GL1X · GenesisL1 explorer

Research workbench

Potent, selective protein tyrosine phosphatase 1B inhibitor compound 12 using a linked-fragment strategy

Analyse Potent, selective protein tyrosine phosphatase 1B inhibitor compound 12 using a… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
1NL9
Type
protein
Length
282 residues
Chains
1
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Protein-tyrosine phosphatase, non-receptor type 1
EC
3.1.3.48
UniProt
P18031
Ligands
989
Pockets
1 · best druggability 0.47

Structure

x-ray diffraction · 1 distinct chain · 37% helix, 21% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
AProtein-tyrosine phosphatase, non-receptor type 1 (EC 3.1.3.48)protein28237% helix, 21% strandP18031

Ligands and binding sites

  • 989 · 2-{[4-(2-acetylamino-2-pentylcarbamoyl-ethyl)-naphthalen-1-yl]-oxalyl-amino}-benzoic acid · ligand · chains A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 0 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
11650.470.7623989

Compared structures

  • 1NL9 · Potent, Selective Protein Tyrosine Phosphatase 1B Inhibitor Compound 12 Using a… · the same entry in another collection · chain A against A, TM-score 1.00

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.